IEEE Pulse最新文献

Noninvasive ultrasound devices are in development to treat dementia, arthritis, chronic pain and other health conditions.

Migraine, a debilitating neurological disorder affecting over 1 billion people worldwide, has long challenged medical science due to its complex pathophysiology and variable treatment responses. Single-pulse transcranial magnetic stimulation (sTMS), a noninvasive central neuromodulation technique, has emerged as a promising therapeutic option. Developed by eNeura Inc., the SAVI Dual device leverages sTMS to provide both acute and preventive migraine relief by targeting hyperactive neural networks in the brain. This article explores the technical underpinnings of SAVI Dual, traces the history of clinical studies that shaped sTMS for neuromodulation, and evaluates its position within the evolving migraine market.

While robotic-assisted surgery has opened new frontiers for medical interventions, benefits haven't come without a cost. Surgeons have had to adapt to operating deep within a patient's body without a sense of touch. The technology to restore that sensation-haptic feedback-has been a research goal since robots were first introduced into the operating room. Intuitive Surgical in March 2024 announced that its new da Vinci 5 robotics platform would include integrated force feedback haptic technology-the first FDA-approved system to do so. Using it, surgeons can sense push and pull forces, feel tissue tension, and detect pressure from common tasks such as dissection, retraction, and suturing. But force feedback is only one part of haptics. Finer tactile sensations could open up new possibilities for robotic surgery. Researchers around the globe are developing promising approaches to provide tactile experiences, including at the University of California San Diego, where a team has developed a stretchable, conductive polymer that delivers low-current electrical signals to fingertips.

The future of health care is poised for a transformative shift. Driven by the evolution of surgical robotics, artificial intelligence (AI), and an interconnected ecosystem, health practitioners will be empowered to make procedures more precise, predictable, and personalized. This article explores emerging technologies in surgery that augment a surgeon's hands (robotics), eyes (medical imaging), and brain (AI-driven ecosystems). In robotics, endoluminal approaches and telesurgery are revolutionizing minimally invasive techniques and expanding access to care globally. Advanced visualization using patient specific models and new imaging modalities are enhancing surgical navigation and giving practitioners the ability to see the unseen. AI and data-driven platforms are increasing precision, optimizing clinical workflows, and reducing complications. As we continue to push the boundaries of MedTech innovation, the growing synergy between these technologies will make procedures more safe, more efficient, and more accessible-ultimately redefining surgical standards.

A pill-sized remote-operated vehicle that takes and transmits live video of the inside of a person's stomach could be on the market as early as 2026.

We live in a world where robots can operate with a level of precision that is hard for humans to match, and robotic laparoscopic surgery has become familiar if not commonplace. Until now, surgical tools have always been firmly in the control of experienced human surgeons, but the advent of sophisticated artificial intelligence (AI) systems allows us to envisage a future in which technology does the thinking and the decision-making in increasingly complex procedures. Already, there are systems that are capable of suturing wounds in some instances, and AI is greatly efficiency and accuracy with which medical imagery is analyzed, so it is likely that AI will soon play a bigger role in determining clinical choices and performing surgical procedures. But many questions remain about whether fully autonomous robotic surgery is possible, necessary, desirable, and ethical. In this article, we examine how the role AI currently plays in robotic surgery, where it has potentially valuable applications, and how far it must progress to reach some level of autonomy, as well as exploring the ethical, practical, and regulatory factors that might keep AI in check.

A career that spans the 37 years since "tissue engineering" was coined is chronicled, including selected research and translation highlights of the author in cardiovascular applications.

University of Chicago researchers have developed an ultra-lightweight, paper-thin, catheter-delivered cardiac pacemaker. Tested on a live pig, the pacemaker successfully regulated the heartbeat via tiny pulses of light. The design permits adjustments to the pacing as well as location of heart stimulation.

Artificial intelligence (AI) is becoming all-pervasive, impacting our lives in ways that are sometimes visible, but at other times hidden. Algorithms that learn from data-be it consumer preferences, medical imaging data, or any other dataset-are influencing decisions and choices in every industry, and health care is no exception. When patient outcomes are at stake this raises questions of ethics, accountability, and accuracy. This article looks at how AI is currently being put to work in cardiology, how its range of applications might expand, and how health care professionals and technologists can work together to ensure that it is deployed in a way that is safe, efficient, and beneficial for all patients.

This article is an in-depth examination of the role of pediatric device consortia (PDC) in the development of innovative devices. Looking at the funding model, and at how the challenges that arise in the development of medical devices differ from the development of drug therapies, the article looks at how PDCs can help OEMs with not only funding, but also expertise, regulatory guidance, and more. There is also an examination of some successful devices that have been backed by PDCs, and a comparison with how pediatric devices are funded in Europe to who how the true value of the FDA's PDC grant program.